(MENAFN- Newsfile Corp) Nutanix Shareholder Notice
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Nutanix To Contact Him Directly To Discuss Their Options
New York, New York--(Newsfile Corp. - March 17, 2023) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Nutanix, Inc. ('Nutanix' or the 'Company') (NASDAQ: NTNX).
If you suffered losses exceeding $50,000 investing in Nutanix stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310) . You may also click here for additional information: .
There is no cost or obligation to you.
Faruqi & Faruqi is a leading minority and Woman-owned national securities law firm with offices in New York, Pennsylvania, California and Georgia.
On March 6, 2023, after the market closed, Nutanix disclosed that it will be unable to file its Quarterly Report on Form 10-Q for the quarter ended January 31, 2023 on time because the Company's Audit Committee is conducting an investigation with the assistance of outside counsel. The investigation relates to 'certain evaluation software from one of the Company's third-party providers [that] was instead used for interoperability testing, validation and customer proofs of concept over a multi-year period.' The Company further disclosed that the issue is likely to result in 'additional costs . . . incurred to address the additional use of the software.'
On this news, Nutanix's stock price fell $2.27, or 7.8%, to close at $26.50 per share on March 7, 2023, thereby injuring investors.
Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP ( ). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.
To view the source version of this press release, please visit
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.